RXST · RxSight Inc. Common Stock
View on chartInsiders & Stakes
| Eric Weinberg Chief Commercial Officer | ▲ Buy | Option Exercise | 235,516 Shares held | 9/15/2026 | View profile |
| Jesse Anderson Corley Director | ▲ Buy | Grant | 86,227 Shares held | 6/17/2026 | View profile |
| Bakker Juliet Tammenoms Director | ▲ Buy | Grant | 85,183 Shares held | 6/17/2026 | View profile |
| Ilya Goldshleger Chief Operating Officer | ▼ Sell | Open Market | 81,509 Shares held | 9/2/2026 | View profile |
| Julie Andrews Director | ▲ Buy | Grant | 78,076 Shares held | 6/17/2026 | View profile |
| Robert Keith Warner Director | ▲ Buy | Grant | 78,076 Shares held | 6/17/2026 | View profile |
| Robert J. Palmisano Director | ▲ Buy | Grant | 78,076 Shares held | 6/17/2026 | View profile |
| William J. Link, PhD Director | ▲ Buy | Grant | 74,892 Shares held | 6/17/2026 | View profile |
| Tamara Fountain Director | ▲ Buy | Grant | 72,582 Shares held | 6/17/2026 | View profile |
| Kurtz Ronald M MD President & CEO | ▼ Sell | Open Market | 71,775 Shares held | 9/2/2026 | View profile |
| Raymond W. Cohen Director | ▲ Buy | Grant | 66,532 Shares held | 6/17/2026 | View profile |
| Shweta Maniar Director | ▲ Buy | Grant | 55,172 Shares held | 6/17/2026 | View profile |
| Shelley B. Thunen Chief Financial Officer | ▲ Buy | Option Exercise | 38,354 Shares held | 4/14/2025 | View profile |
| Mark Wilterding Chief Financial Officer | ▼ Sell | Open Market | 25,049 Shares held | 9/2/2026 | View profile |
| Scott Gaines Chief Customer Officer | ▼ Sell | Tax Withholding | 14,848 Shares held | 2/28/2026 | View profile |
Transaction History
| Eric Weinberg | ▲ Buy | Option Exercise | 35,168 | $153K | 9/15/2026 |
| Mark Wilterding | ▼ Sell | Open Market | 7,765 | $54K | 9/2/2026 |
| Ilya Goldshleger | ▼ Sell | Open Market | 2,041 | $14K | 9/2/2026 |
| Eric Weinberg | ▼ Sell | Open Market | 2,041 | $14K | 9/2/2026 |
| Kurtz Ronald M MD | ▼ Sell | Open Market | 5,100 | $35K | 9/2/2026 |
| Eric Weinberg | ▲ Buy | Option Exercise | 5,370 | — | 8/31/2026 |
| Kurtz Ronald M MD | ▲ Buy | Option Exercise | 13,425 | — | 8/31/2026 |
| Mark Wilterding | ▲ Buy | Option Exercise | 20,441 | — | 8/31/2026 |
| Ilya Goldshleger | ▲ Buy | Option Exercise | 5,370 | — | 8/31/2026 |
| Tamara Fountain | ▲ Buy | Grant | 37,037 | — | 6/17/2026 |
| Raymond W. Cohen | ▲ Buy | Grant | 30,864 | — | 6/17/2026 |
| Julie Andrews | ▲ Buy | Grant | 37,037 | — | 6/17/2026 |
| William J. Link, PhD | ▲ Buy | Grant | 37,037 | — | 6/17/2026 |
| Jesse Anderson Corley | ▲ Buy | Grant | 37,037 | — | 6/17/2026 |
| Robert Keith Warner | ▲ Buy | Grant | 37,037 | — | 6/17/2026 |
| Robert J. Palmisano | ▲ Buy | Grant | 37,037 | — | 6/17/2026 |
| Shweta Maniar | ▲ Buy | Grant | 37,037 | — | 6/17/2026 |
| Bakker Juliet Tammenoms | ▲ Buy | Grant | 37,037 | — | 6/17/2026 |
| Ilya Goldshleger | ▲ Buy | Option Exercise | 12,489 | $52K | 4/17/2026 |
| Scott Gaines | ▼ Sell | Tax Withholding | 2,580 | $20K | 2/28/2026 |
| Mark Wilterding | ▲ Buy | Option Exercise | 20,441 | — | 2/28/2026 |
| Mark Wilterding | ▼ Sell | Tax Withholding | 8,068 | $61K | 2/28/2026 |
| Scott Gaines | ▲ Buy | Option Exercise | 6,261 | — | 2/28/2026 |
| Ilya Goldshleger | ▲ Buy | Option Exercise | 15,096 | $66K | 9/25/2025 |
| Ilya Goldshleger | ▲ Buy | Option Exercise | 8,349 | $34K | 9/25/2025 |
| Raymond W. Cohen | ▲ Buy | Grant | 35,668 | $0 | 7/31/2025 |
| William J. Link, PhD | ▲ Buy | Grant | 10,752 | — | 6/3/2025 |
| Tamara Fountain | ▲ Buy | Grant | 10,752 | — | 6/3/2025 |
| Robert Keith Warner | ▲ Buy | Grant | 10,752 | — | 6/3/2025 |
| Shweta Maniar | ▲ Buy | Grant | 10,752 | — | 6/3/2025 |
| Robert J. Palmisano | ▲ Buy | Grant | 10,752 | — | 6/3/2025 |
| Julie Andrews | ▲ Buy | Grant | 10,752 | — | 6/3/2025 |
| Bakker Juliet Tammenoms | ▲ Buy | Grant | 10,752 | — | 6/3/2025 |
| Jesse Anderson Corley | ▲ Buy | Grant | 10,752 | — | 6/3/2025 |
| Eric Weinberg | ▲ Buy | Option Exercise | 188,002 | $739K | 6/2/2025 |
| Shelley B. Thunen | ▲ Buy | Option Exercise | 7,792 | $34K | 4/14/2025 |
| Tamara Fountain | ▼ Sell | Open Market | 7,000 | $180K | 3/12/2025 |
| Shweta Maniar | ▼ Sell | Open Market | 3,519 | $109K | 1/22/2025 |
| Jesse Anderson Corley | ▲ Buy | Open Market | 1,767 | $55K | 1/16/2025 |
| Jesse Anderson Corley | ▲ Buy | Open Market | 1,443 | $45K | 1/15/2025 |
| Ilya Goldshleger | ▼ Sell | Open Market | 3,105 | $143K | 11/29/2024 |
| Ilya Goldshleger | ▲ Buy | Option Exercise | 3,105 | $47K | 11/29/2024 |
| Shweta Maniar | ▼ Sell | Open Market | 3,782 | $174K | 11/26/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 3,100 | $142K | 11/26/2024 |
| Ilya Goldshleger | ▲ Buy | Option Exercise | 3,100 | $47K | 11/26/2024 |
| Ilya Goldshleger | ▲ Buy | Option Exercise | 3,100 | $47K | 11/22/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 3,100 | $140K | 11/22/2024 |
| Ilya Goldshleger | ▲ Buy | Option Exercise | 3,100 | $47K | 11/18/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 3,067 | $138K | 11/18/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 33 | $1K | 11/18/2024 |
| Ilya Goldshleger | ▲ Buy | Option Exercise | 4,875 | $74K | 11/15/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 4,875 | $224K | 11/15/2024 |
| Jesse Anderson Corley | ▲ Buy | Open Market | 5,570 | $251K | 11/13/2024 |
| Jesse Anderson Corley | ▲ Buy | Open Market | 4,090 | $184K | 11/13/2024 |
| Jesse Anderson Corley | ▲ Buy | Open Market | 1,705 | $76K | 11/13/2024 |
| Ilya Goldshleger | ▲ Buy | Option Exercise | 1,330 | $20K | 11/12/2024 |
| Jesse Anderson Corley | ▲ Buy | Open Market | 11,111 | $504K | 11/12/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 1,330 | $61K | 11/12/2024 |
| Ilya Goldshleger | ▲ Buy | Option Exercise | 3,100 | $47K | 11/7/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 2,900 | $159K | 11/7/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 200 | $11K | 11/7/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 260 | $13K | 11/4/2024 |
| Ilya Goldshleger | ▲ Buy | Option Exercise | 3,100 | $47K | 11/4/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 2,840 | $145K | 11/4/2024 |
| Ilya Goldshleger | ▲ Buy | Option Exercise | 3,105 | $47K | 10/30/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 3,105 | $161K | 10/30/2024 |
| Ilya Goldshleger | ▲ Buy | Option Exercise | 3,100 | $47K | 10/28/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 3,100 | $157K | 10/28/2024 |
| Ilya Goldshleger | ▲ Buy | Option Exercise | 3,100 | $47K | 10/25/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 3,100 | $154K | 10/25/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 3,100 | $154K | 10/22/2024 |
| Ilya Goldshleger | ▲ Buy | Option Exercise | 3,100 | $47K | 10/22/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 69 | $3K | 10/18/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 34 | $2K | 10/18/2024 |
| Ilya Goldshleger | ▲ Buy | Option Exercise | 3,105 | $47K | 10/18/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 3,002 | $150K | 10/18/2024 |
| Ilya Goldshleger | ▲ Buy | Option Exercise | 3,100 | $47K | 10/16/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 3,100 | $154K | 10/16/2024 |
| Ilya Goldshleger | ▲ Buy | Option Exercise | 3,100 | $47K | 10/14/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 3,100 | $155K | 10/14/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 3,100 | $156K | 10/11/2024 |
| Ilya Goldshleger | ▲ Buy | Option Exercise | 3,100 | $47K | 10/11/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 3,105 | $152K | 10/10/2024 |
| Ilya Goldshleger | ▲ Buy | Option Exercise | 3,105 | $47K | 10/10/2024 |
| Ilya Goldshleger | ▲ Buy | Option Exercise | 3,100 | $47K | 10/8/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 3,100 | $150K | 10/8/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 2,866 | $137K | 10/4/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 206 | $10K | 10/4/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 28 | $1K | 10/4/2024 |
| Ilya Goldshleger | ▲ Buy | Option Exercise | 3,100 | $47K | 10/4/2024 |
| Shelley B. Thunen | ▲ Buy | Option Exercise | 15,000 | $240K | 10/1/2024 |
| Shelley B. Thunen | ▼ Sell | Open Market | 9,521 | $464K | 10/1/2024 |
| Shelley B. Thunen | ▼ Sell | Open Market | 278 | $14K | 10/1/2024 |
| Shelley B. Thunen | ▼ Sell | Open Market | 5,201 | $249K | 10/1/2024 |
| Ilya Goldshleger | ▲ Buy | Option Exercise | 3,100 | $47K | 9/30/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 1,448 | $72K | 9/30/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 1,652 | $80K | 9/30/2024 |
| Ilya Goldshleger | ▲ Buy | Option Exercise | 3,105 | $47K | 9/26/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 3,105 | $153K | 9/26/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 150 | $8K | 9/23/2024 |
| Ilya Goldshleger | ▲ Buy | Option Exercise | 3,100 | $47K | 9/23/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 2,950 | $155K | 9/23/2024 |
| Ilya Goldshleger | ▲ Buy | Option Exercise | 3,100 | $47K | 9/20/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 3,100 | $165K | 9/20/2024 |
| Ilya Goldshleger | ▲ Buy | Option Exercise | 3,100 | $47K | 9/17/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 3,100 | $174K | 9/17/2024 |
| Kurtz Ronald M MD | ▲ Buy | Option Exercise | 7,650 | $115K | 8/9/2024 |
| Kurtz Ronald M MD | ▲ Buy | Option Exercise | 2,300 | $10K | 8/9/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 1,827 | $71K | 8/5/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 1,145 | $44K | 8/5/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 1,087 | $42K | 8/5/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 1,913 | $76K | 8/5/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 1,855 | $73K | 8/5/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 1,173 | $47K | 8/5/2024 |
| Shelley B. Thunen | ▲ Buy | Option Exercise | 16,505 | $72K | 7/15/2024 |
| Kurtz Ronald M MD | ▲ Buy | Option Exercise | 13,500 | $204K | 7/11/2024 |
| Shelley B. Thunen | ▲ Buy | Option Exercise | 10,000 | $156K | 7/1/2024 |
| Shelley B. Thunen | ▼ Sell | Open Market | 1,803 | $107K | 7/1/2024 |
| Shelley B. Thunen | ▼ Sell | Open Market | 8,146 | $476K | 7/1/2024 |
| Shelley B. Thunen | ▼ Sell | Open Market | 6,599 | $386K | 7/1/2024 |
| Shelley B. Thunen | ▼ Sell | Open Market | 1,854 | $110K | 7/1/2024 |
| Julie Andrews | ▼ Sell | Open Market | 11,940 | $691K | 6/14/2024 |
| Julie Andrews | ▼ Sell | Open Market | 3,685 | $216K | 6/14/2024 |
| William J. Link, PhD | ▲ Buy | Grant | 2,554 | — | 6/6/2024 |
| Jesse Anderson Corley | ▲ Buy | Grant | 2,554 | — | 6/6/2024 |
| Julie Andrews | ▲ Buy | Grant | 2,554 | — | 6/6/2024 |
| Tamara Fountain | ▲ Buy | Grant | 2,554 | — | 6/6/2024 |
| Bakker Juliet Tammenoms | ▲ Buy | Grant | 2,554 | — | 6/6/2024 |
| Shweta Maniar | ▲ Buy | Grant | 2,554 | — | 6/6/2024 |
| Robert J. Palmisano | ▲ Buy | Grant | 2,554 | — | 6/6/2024 |
| Robert Keith Warner | ▲ Buy | Grant | 2,554 | — | 6/6/2024 |
| Bakker Juliet Tammenoms | ▲ Buy | Open Market | 5,000 | $305K | 5/17/2024 |
| Ilya Goldshleger | ▲ Buy | Option Exercise | 15,667 | $62K | 5/17/2024 |
| Ilya Goldshleger | ▲ Buy | Option Exercise | 4,840 | $20K | 5/17/2024 |
| Ilya Goldshleger | ▲ Buy | Option Exercise | 4,264 | $19K | 5/17/2024 |
| Kurtz Ronald M MD | ▼ Sell | Open Market | 40,000 | $2.4M | 5/3/2024 |
| Shelley B. Thunen | ▼ Sell | Open Market | 9,620 | $507K | 5/1/2024 |
| Shelley B. Thunen | ▲ Buy | Option Exercise | 10,247 | $160K | 5/1/2024 |
| Shelley B. Thunen | ▼ Sell | Open Market | 380 | $20K | 5/1/2024 |
| Shelley B. Thunen | ▼ Sell | Open Market | 543 | $28K | 4/1/2024 |
| Shelley B. Thunen | ▼ Sell | Open Market | 200 | $10K | 4/1/2024 |
| Shelley B. Thunen | ▼ Sell | Open Market | 8,857 | $441K | 4/1/2024 |
| Shelley B. Thunen | ▼ Sell | Open Market | 800 | $40K | 4/1/2024 |
| Shelley B. Thunen | ▼ Sell | Open Market | 8,938 | $445K | 4/1/2024 |
| Shelley B. Thunen | ▼ Sell | Open Market | 662 | $33K | 4/1/2024 |
| Shelley B. Thunen | ▲ Buy | Option Exercise | 10,000 | $156K | 3/1/2024 |
| Shelley B. Thunen | ▼ Sell | Open Market | 6,361 | $359K | 3/1/2024 |
| Shelley B. Thunen | ▼ Sell | Open Market | 2,473 | $141K | 3/1/2024 |
| Shelley B. Thunen | ▼ Sell | Open Market | 1,166 | $64K | 3/1/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 5,000 | $280K | 2/16/2024 |
| Ilya Goldshleger | ▲ Buy | Option Exercise | 10,000 | $230K | 2/16/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 5,000 | $275K | 2/16/2024 |
| Ilya Goldshleger | ▲ Buy | Option Exercise | 10,000 | $230K | 2/15/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 5,000 | $265K | 2/15/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 5,000 | $270K | 2/15/2024 |
| Ilya Goldshleger | ▲ Buy | Option Exercise | 5,000 | $115K | 2/14/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 5,000 | $260K | 2/14/2024 |
| Bakker Juliet Tammenoms | ▲ Buy | Open Market | 4,000 | $205K | 2/14/2024 |
| Bakker Juliet Tammenoms | ▲ Buy | Open Market | 4,000 | $202K | 2/12/2024 |
| Ilya Goldshleger | ▲ Buy | Option Exercise | 5,000 | $115K | 2/9/2024 |
| Ilya Goldshleger | ▲ Buy | Option Exercise | 5,365 | $101K | 2/9/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 5,365 | $271K | 2/9/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 5,000 | $255K | 2/9/2024 |
| Shelley B. Thunen | ▲ Buy | Option Exercise | 15,875 | $237K | 2/6/2024 |
| Shelley B. Thunen | ▼ Sell | Open Market | 15,875 | $754K | 2/6/2024 |
| Shelley B. Thunen | ▲ Buy | Option Exercise | 6,900 | $30K | 2/5/2024 |
| Shelley B. Thunen | ▲ Buy | Option Exercise | 9,125 | $136K | 2/5/2024 |
| Shelley B. Thunen | ▼ Sell | Open Market | 9,125 | $429K | 2/5/2024 |
| Jesse Anderson Corley | ▼ Sell | Gift | 7,083 | $0 | 2/5/2024 |
| Jesse Anderson Corley | ▼ Sell | Gift | 7,083 | $0 | 2/5/2024 |
| Jesse Anderson Corley | ▼ Sell | Gift | 46,884 | $0 | 2/5/2024 |
| Jesse Anderson Corley | ▼ Sell | Gift | 46,884 | $0 | 2/5/2024 |
| Ilya Goldshleger | ▲ Buy | Option Exercise | 6,539 | $124K | 2/1/2024 |
| Ilya Goldshleger | ▲ Buy | Option Exercise | 590 | $14K | 2/1/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 590 | $30K | 2/1/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 3,000 | $149K | 2/1/2024 |
| William J. Link, PhD | ▼ Sell | Open Market | 20,598 | $1.0M | 2/1/2024 |
| William J. Link, PhD | ▼ Sell | Open Market | 7,652 | $383K | 2/1/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 3,539 | $173K | 2/1/2024 |
| Eric Weinberg | ▼ Sell | Open Market | 10,000 | $500K | 2/1/2024 |
| William J. Link, PhD | ▼ Sell | Gift | 3,000 | $0 | 2/1/2024 |
| Shelley B. Thunen | ▲ Buy | Option Exercise | 31,772 | $479K | 1/26/2024 |
| Shelley B. Thunen | ▼ Sell | Open Market | 31,772 | $1.5M | 1/26/2024 |
| Shelley B. Thunen | ▲ Buy | Option Exercise | 4,500 | $20K | 1/26/2024 |
| Eric Weinberg | ▼ Sell | Open Market | 10,000 | $480K | 1/22/2024 |
| Ilya Goldshleger | ▲ Buy | Option Exercise | 5,000 | $95K | 1/22/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 5,000 | $240K | 1/22/2024 |
| Shweta Maniar | ▼ Sell | Open Market | 3,520 | $161K | 1/18/2024 |
| Shweta Maniar | ▼ Sell | Open Market | 2,879 | $132K | 1/18/2024 |
| Ilya Goldshleger | ▲ Buy | Option Exercise | 5,000 | $95K | 1/9/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 5,000 | $235K | 1/9/2024 |
| Eric Weinberg | ▼ Sell | Open Market | 10,000 | $460K | 1/9/2024 |
| Jesse Anderson Corley | ▼ Sell | Open Market | 2,000 | $90K | 1/8/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 5,000 | $225K | 1/8/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 5,000 | $210K | 1/8/2024 |
| Ilya Goldshleger | ▼ Sell | Open Market | 5,000 | $215K | 1/8/2024 |
| Eric Weinberg | ▼ Sell | Open Market | 10,000 | $420K | 1/8/2024 |
| Robert Keith Warner | ▼ Sell | Open Market | 16,530 | $700K | 1/8/2024 |
| Robert Keith Warner | ▼ Sell | Open Market | 7,220 | $314K | 1/8/2024 |
| Shweta Maniar | ▼ Sell | Open Market | 6,418 | $289K | 1/8/2024 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
BofA Lowers RxSight Target to $5.5 Amid Growth Headwinds
Bank of America analysts say RxSight's potential for utilization growth is limited by structural and competitive challenges. They lowered the price target to $5.50 and keep an underperform rating. The stock is trading near its 52‑week low and close to a support level of $4.88.
BofA Lowers RxSight Target to $5.5 Amid Growth Headwinds. Bank of America analysts say RxSight's potential for utilization growth is limited by structural and competitive challenges. They lowered the price target to $5.50 and keep an underperform rating. The stock is trading near its 52‑week low and close to a support level of $4.88.